Breaking News Instant updates and real-time market news.

NKE

Nike

$50.96

-1.936 (-3.66%)

, KR

Kroger

$21.24

-3.32 (-13.52%)

10:50
06/16/17
06/16
10:50
06/16/17
10:50

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Nike (NKE) downgraded to Neutral from Overweight at JPMorgan with analyst Matthew Boss saying his work suggests Nike's sales in North America are likely to get worse before getting better. 2. Kroger (KR) downgraded to Neutral from Buy at Goldman Sachs, to Neutral from Overweight at JPMorgan, and to Market Perform from Outperform at Telsey Advisory. 3. Booz Allen (BAH) was downgraded to Neutral from Buy at BofA/Merrill, to Hold from Buy at Vertical Research, and to Market Perform from Outperform at Raymond James. 4. Square (SQ) downgraded to Neutral from Outperform at Credit Suisse with analyst Paul Condra saying the shares at current levels are fully valued. 5. Noble Corp. (NE) downgraded to Neutral from Buy at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

NKE

Nike

$50.96

-1.936 (-3.66%)

KR

Kroger

$21.24

-3.32 (-13.52%)

BAH

Booz Allen

$31.70

-7.63 (-19.40%)

SQ

Square

$23.64

-0.35 (-1.46%)

NE

Noble Corp.

$3.78

-0.045 (-1.18%)

  • 19

    Jun

  • 20

    Jun

  • 22

    Jun

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

  • 29

    Jun

NKE Nike
$50.96

-1.936 (-3.66%)

06/16/17
JPMS
06/16/17
DOWNGRADE
Target $58
JPMS
Neutral
Nike downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Matthew Boss downgraded Nike to Neutral and lowered his price target for the shares to $58 from $61. The footwear giant closed yesterday down 3%, or $1.76, to $52.90. The analyst's work suggests Nike's sales in North America are likely to get worse before getting better. The company changes announced this week will take time, Boss tells investors in a research note. The analyst, however, is "encouraged" by management's cost reductions and "forward thinking initiatives."
06/16/17
BARD
06/16/17
NO CHANGE
Target $62
BARD
Outperform
Nike restructuring a replay of 2009, suggests buying opportunity, says Baird
Baird analyst Jonathan Komp noted Nike has undergone multiple restructurings, stating that the current one appears to be a replay of its 2009 strategy, which resulted in a very strong multi-year stretch of outperformance for the stock. The analyst said the playbook suggest a compelling buying opportunity post Q4 earnings. Komp maintained his Outperform rating and $62 price target on Nike shares.
06/01/17
PIPR
06/01/17
NO CHANGE
Target $50
PIPR
Neutral
Piper 'firmly' believes too early to buy Nike shares
Piper Jaffray analyst Erinn Murphy believes Nike's innovation pipeline "has paused" while competition "remains fierce." The analyst "firmly" believes it remains too early to buy Nike shares. To reflect further gross margin pressures and currency moves, the analyst lowered her FY18 earnings estimate to $2.40 from $2.44 and price target to $50 from $51. Murphy expects Nike management, in due course, will lower their long-term targets. She keeps a Neutral rating on the shares.
06/13/17
ARGS
06/13/17
DOWNGRADE
ARGS
Hold
Foot Locker downgraded to Hold from Buy at Argus
Argus analyst John Staszak downgraded Foot Locker (FL) based on weakening demand for Nike (NKE) footwear. The analyst says that Nike footwear generates more than two-thirds of Foot Locker's revenue, and he thinks that the retailer will have difficulty reaching 5% comp sales growth in the second half of fiscal 2018.
KR Kroger
$21.24

-3.32 (-13.52%)

06/16/17
RBCM
06/16/17
NO CHANGE
RBCM
Kroger risk/reward 'favorable,' says RBC Capital
After Kroger lowered its fiscal 2017 EPS guidance. RBC Capital analyst William Kirk says that the company's increased investments in prices and labor are "alarming." However, the analyst notes that the company still had positive ID sales so far this quarter, and he thinks that it will benefit from the closure of a number of competing stores. He says that the stock's risk/reward ratio is positive, and he keeps an Outperform rating on the stock.
06/16/17
WELS
06/16/17
NO CHANGE
WELS
Kroger price target lowered to $28 from $35 at Wells Fargo
Wells Fargo cut its price target on Kroger after the company lowered its fiscal 2017 EPS guidance. The firm says that the company's investments in prices was larger than expected amid tough competition. However, Wells believes that the company is taking the necessary steps to preserve its market share, and it believes that the stock can reward patient investors. It keeps an Outperform rating on the shares.
06/16/17
GUGG
06/16/17
NO CHANGE
GUGG
Performance Food added to Best Ideas List, Kroger removed at Guggenheim
06/16/17
BARD
06/16/17
NO CHANGE
Target $72
BARD
Outperform
Amazon deal for Whole Foods a 'mild negative' for Vantiv, says Baird
Baird analyst David Koning believes Whole Foods (WFM) could be about 0.15-0.2% of Vantiv's (VNTV) revenue, making the deal for the grocer to be acquired by Amazon (AMZN) a "mild negative" for Vantiv. Vantiv may trade down today following that news and the guidance cut from Kroger (KR), which Koning estimates accounts for about 1% of Vantiv's revenue. However, he likes Vantiv shares given its valuation and potential for rising estimates and keeps an Outperform rating and $72 price target on the stock.
BAH Booz Allen
$31.70

-7.63 (-19.40%)

06/16/17
VERT
06/16/17
DOWNGRADE
VERT
Hold
Booz Allen downgraded to Hold from Buy at Vertical Research
06/16/17
WELS
06/16/17
NO CHANGE
WELS
Booz Allen still has multiple positive catalysts, says Wells Fargo
After Booz Allen announced that the Department of Justice was conducting a civil and criminal probe of its accounting and charging practices involving the government, Wells Fargo says that past legal/political issues involving the company have given investors good opportunities to buy the stock at attractive prices. The firm notes that the company has not been indicted. Wells remains upbeat on the company's strong brand, market positioning,and ability to benefit from "unusually strong government fiscal year-end award activity." Wells trimmed its price target on the shares to $40 from $43 but keeps an Outperform rating.
06/16/17
SBSH
06/16/17
NO CHANGE
Target $41
SBSH
Neutral
Citi sees 'more questions than answers' for Booz Allen
Citi analyst Jonathan Raviv sees "more questions than answers" after Booz Allen Hamilton disclosed a Department of Justice civil and criminal investigation relating to elements of the company's cost accounting and indirect cost charging practices. A share selloff is warranted as the disclosure "takes some shine off, especially for a stock that has typically traded at a premium," Raviv tells investors in a research note. He notes that an 8% yield to his FY19 free cash flow per share estimate yields a $28 stock. The analyst has a Neutral rating on Booz Allen with a $41 price target. The stock in premarket trading is down 16%, or $6.23, to $33.10.
06/16/17
BOFA
06/16/17
DOWNGRADE
BOFA
Neutral
Booz Allen downgraded to Neutral from Buy at BofA/Merrill
SQ Square
$23.64

-0.35 (-1.46%)

05/17/17
DBAB
05/17/17
NO CHANGE
Target $23
DBAB
Buy
Square in early innings of 'upward trajectory,' says Deutsche Bank
Deutsche Bank analyst Bryan Keane says he still believes Square is in the early innings of its "upward trajectory" following the company's analyst day. He feels the stock's momentum will continue and upped his price target for the shares to $23 from $21. The analyst reiterates a Buy rating on the name.
05/17/17
05/17/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Disney (DIS) downgraded to Neutral from Outperform at Macquarie with analyst Tim Nollen saying the company's exposure to cable and "outsized" subscriber declines at ESPN "have again become a focal point in investors' minds." 2. Pandora (P) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Heath Terry saying he was wrong in thinking the market would focus on new subscription products and a return to profitability by the fourth quarter. 3. Square (SQ) downgraded to Neutral from Buy at BTIG with analyst Mark Palmer citing valuation following the strong rally and removed his $20 price target. 4. AMD (AMD) downgraded to Hold from Buy at Loop Capital with analyst Betsy Van Hees saying she believes the stock is fairly valued and is already pricing in "a lot," including the launches of RYZEN CPUs, Vega GPUs and the new EPYC server chip. 5. Etsy (ETSY) downgraded to Hold from Buy at Loop Capital with analyst Blake Harper saying with Etsy's new management team undertaking an internal strategic and operational review, an imminent sale of the company is unlikely. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/19/17
TIGR
05/19/17
INITIATION
TIGR
Buy
Square initiated with a Buy at Tigress Financial
Tigress Financial analyst Ivan Feinseth started Square with a Buy rating.
06/16/17
FBCO
06/16/17
DOWNGRADE
Target $25
FBCO
Neutral
Square downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Paul Condra downgraded Square to Neutral saying the shares at current levels are fully valued. Condra is "positive" on the business but notes the stock is up 20% since last month's analyst day. He raised his price target for the shares to $25 from $20.
NE Noble Corp.
$3.78

-0.045 (-1.18%)

03/07/17
GHSC
03/07/17
UPGRADE
Target $8
GHSC
Buy
Noble Corp. upgraded to Buy from Neutral at Seaport Global
Seaport Global analyst Mark Brown upgraded Noble to Buy with an $8 price target due to valuation and expectations for a pickup in drilling later in 2017.
06/16/17
SBSH
06/16/17
DOWNGRADE
Target $4.7
SBSH
Neutral
Noble Corp. downgraded to Neutral from Buy at Citi
Citi analyst Scott Gruber downgraded Noble Corp. to Neutral and lowered his price target for the shares to $4.70 from $11. To reflect lower oil prices, the analyst dropped his price targets across the offshore driller space. He also notes Noble faces an outstanding legal case by bondholders of Paragon.
05/18/17
NOMU
05/18/17
UPGRADE
NOMU
Neutral
Noble Corp. upgraded to Neutral from Reduce at Nomura Instinet
Nomura Instinet analyst Matthew Johnston upgraded Noble Corp to Neutral from Reduce saying valuation is approaching "washed out" levels and lowered its price target to $5 from $6.
03/07/17
03/07/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Hyatt (H) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Thomas Allen saying shares are trading in-line with his price target adn offer more attractive risk/reward. 2. Noble Corp. (NE) upgraded to Buy from Neutral at Seaport Global with analyst Mark Brown citing valuation and expectations for a pickup in drilling later in 2017. 3. Weatherford (WFT) upgraded to Overweight from Equalweight at Capital One with analyst Luke Lemoine saying the hiring of Mark McCollum, Halliburton's (HAL) CFO, adds legitimacy and credibility to Weatherford's status as a turnaround story. 4. Bill Barrett (BBG) upgraded to Buy from Hold at Canaccord with analyst Stephen Berman saying he sees strong 2018 growth, a solid liquidity position, and said shares are almost 50% from its 52-week high. 5. TSMC (TSM) upgraded to Buy from Hold at HSBC with analyst Steven Pelayo saying he believes TSMC is reasserting its technology leadership. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

ARQL

ArQule

$1.17

0.03 (2.63%)

, NLNK

NewLink Genetics

$7.36

-0.04 (-0.54%)

04:55
06/24/17
06/24
04:55
06/24/17
04:55
Conference/Events
European Hematology Association to hold a conference »

22nd Congress of the EHA…

ARQL

ArQule

$1.17

0.03 (2.63%)

NLNK

NewLink Genetics

$7.36

-0.04 (-0.54%)

BLUE

bluebird bio

$112.00

-6.5 (-5.49%)

XLRN

Acceleron

$34.10

0.15 (0.44%)

BLCM

Bellicum Pharmaceuticals

$13.39

-0.59 (-4.22%)

CRSP

CRISPR Therapeutics

$16.44

0.3 (1.86%)

AGIO

Agios Pharmaceuticals

$59.18

1.76 (3.07%)

CELG

Celgene

$134.31

0.63 (0.47%)

STML

Stemline

$9.10

0.6 (7.06%)

CTIX

Cellceutix

KPTI

Karyopharm

$9.97

0.01 (0.10%)

RARX

RA Pharmaceuticals

$23.01

0.01 (0.04%)

CDTX

Cidara Therapeutics

$6.70

-0.2 (-2.90%)

GBT

Global Blood Therapeutics

$29.85

0.6 (2.05%)

PTLA

Portola Pharmaceuticals

$56.06

17.81 (46.56%)

TGTX

TG Therapeutics

$11.95

-0.05 (-0.42%)

VSTM

Verastem

$2.32

-0.06 (-2.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 24

    Jun

  • 27

    Jun

  • 29

    Jun

  • 29

    Jun

  • 06

    Jul

  • 11

    Jul

  • 26

    Sep

HIMX

Himax

$8.17

-0.02 (-0.24%)

04:55
06/24/17
06/24
04:55
06/24/17
04:55
Conference/Events
Himax management to meet with Roth Captial »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

ANTM

Anthem

$190.17

-3.19 (-1.65%)

18:58
06/23/17
06/23
18:58
06/23/17
18:58
Periodicals
Anthem to pay $115M to settle data breach lawsuits, Reuters reports »

Anthem has agreed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVU

Supervalu

$2.94

-0.04 (-1.34%)

18:26
06/23/17
06/23
18:26
06/23/17
18:26
Hot Stocks
Supervalu completes acquisition of Unified Grocers »

Supervalu announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GILD

Gilead

$70.52

0.04 (0.06%)

18:14
06/23/17
06/23
18:14
06/23/17
18:14
Periodicals
Gilead no longer a 'value trap,' Barron's reports »

Consistent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 06

    Jul

SONA

Southern National Bancorp

$17.21

0.11 (0.64%)

, EVBS

Eastern Virginia Bankshares

$11.01

0.14 (1.29%)

18:07
06/23/17
06/23
18:07
06/23/17
18:07
Hot Stocks
Southern National Bancorp, Eastern Virginia Bankshares complete merger »

Southern National Bancorp…

SONA

Southern National Bancorp

$17.21

0.11 (0.64%)

EVBS

Eastern Virginia Bankshares

$11.01

0.14 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IAC

IAC

$104.84

0.3 (0.29%)

17:56
06/23/17
06/23
17:56
06/23/17
17:56
Hot Stocks
IAC will not pursue plan to create new class of non-voting stock »

IAC's Board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

EGL

Engility

$27.37

0.26 (0.96%)

17:50
06/23/17
06/23
17:50
06/23/17
17:50
Hot Stocks
Engility to eliminate position of president, COO »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

ADM

Archer Daniels

$41.16

0.13 (0.32%)

17:48
06/23/17
06/23
17:48
06/23/17
17:48
Hot Stocks
ADM Animal Nutrition recalls Rough-N-Ready cattle feed over monensin concerns »

ADM Animal Nutrition, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOYA

Voya Financial

$35.24

0.03 (0.09%)

17:30
06/23/17
06/23
17:30
06/23/17
17:30
Syndicate
Breaking Syndicate news story on Voya Financial »

Voya Financial files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBTX

Independent Bank

$54.85

-1.1 (-1.97%)

, TBK

Triumph Bancorp

17:19
06/23/17
06/23
17:19
06/23/17
17:19
Hot Stocks
Independent Bank to sell nine Colorado branches to TBK Bank »

Independent Bank (IBTX)…

IBTX

Independent Bank

$54.85

-1.1 (-1.97%)

TBK

Triumph Bancorp

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

WUBA

58.com

$43.30

0.87 (2.05%)

17:11
06/23/17
06/23
17:11
06/23/17
17:11
Hot Stocks
Breaking Hot Stocks news story on 58.com »

General Atlantic reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOXA

21st Century Fox

$27.19

0.22 (0.82%)

, LGF.B

Lionsgate

$25.38

0.34 (1.36%)

17:10
06/23/17
06/23
17:10
06/23/17
17:10
Hot Stocks
Box Office Battle: 'Transformers' expected to top 'Cars 3,' 'Wonder Woman' »

Viacom (VIA, VIAB)…

FOXA

21st Century Fox

$27.19

0.22 (0.82%)

LGF.B

Lionsgate

$25.38

0.34 (1.36%)

DIS

Disney

$104.36

0.14 (0.13%)

VIAB

Viacom

$34.11

-0.01 (-0.03%)

LGF.A

Lionsgate

$27.07

0.31 (1.16%)

VIA

Viacom

$39.15

0.1 (0.26%)

SNE

Sony

$38.52

0.11 (0.29%)

FOX

21st Century Fox

$26.93

0.3 (1.13%)

TWX

Time Warner

$99.70

0.3 (0.30%)

CMCSA

Comcast

$39.50

-0.44 (-1.10%)

CMCSK

Comcast

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Jul

  • 03

    Aug

  • 08

    Aug

NVUS

Novus Therapeutics

$6.00

-0.04 (-0.66%)

17:07
06/23/17
06/23
17:07
06/23/17
17:07
Syndicate
Breaking Syndicate news story on Novus Therapeutics  »

Novus Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IDXG

Interpace Diagnostics

$0.88

0.03 (3.53%)

17:05
06/23/17
06/23
17:05
06/23/17
17:05
Hot Stocks
Breaking Hot Stocks news story on Interpace Diagnostics »

Armistice Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNR

Monmouth Real Estate

$14.95

0.26 (1.77%)

17:02
06/23/17
06/23
17:02
06/23/17
17:02
Hot Stocks
Monmouth Real Estate acquires building in Texas for $50.6M »

Monmouth Real Estate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Aug

ARCW

ARC Group

$3.55

0.15 (4.41%)

17:01
06/23/17
06/23
17:01
06/23/17
17:01
Hot Stocks
ARC Group names Drew Kelley as Interim CEO, effective July 1 »

ARC Group Worldwide…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAVM

PAVmed

$4.41

-0.08 (-1.78%)

16:55
06/23/17
06/23
16:55
06/23/17
16:55
Syndicate
PAVmed announces effectiveness of Form S-1 resale registration statement »

PAVmed announced that on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MFSF

MutualFirst Financial

$36.15

0.9 (2.55%)

16:48
06/23/17
06/23
16:48
06/23/17
16:48
Hot Stocks
MutualFirst Financial senior executives enter 10b5-1 trading plans »

On June 23, David Heeter,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$32.10

0.25 (0.78%)

16:46
06/23/17
06/23
16:46
06/23/17
16:46
Hot Stocks
Cisco CEO Charles Robbins enters 10b5-1 trading plan »

On June 21, Charles…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

  • 12

    Jul

  • 12

    Jul

  • 13

    Jul

  • 16

    Aug

SITO

SITO Mobile

$3.66

0.02 (0.55%)

16:43
06/23/17
06/23
16:43
06/23/17
16:43
Hot Stocks
SITO Mobile chairman Paul Pressler resigns »

Effective as of June 23,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REGN

Regeneron

$517.33

-9.2 (-1.75%)

, CELG

Celgene

$134.31

0.63 (0.47%)

16:41
06/23/17
06/23
16:41
06/23/17
16:41
General news
S&P sees mild weekly gain, Nasdaq outperforms as biotech shines »

The S&P finished the…

REGN

Regeneron

$517.33

-9.2 (-1.75%)

CELG

Celgene

$134.31

0.63 (0.47%)

GILD

Gilead

$70.54

0.06 (0.09%)

BIIB

Biogen

$280.32

-0.25 (-0.09%)

VRTX

Vertex

$133.50

-2.03 (-1.50%)

AMGN

Amgen

$172.50

-1.32 (-0.76%)

ABBV

AbbVie

$72.64

-0.54 (-0.74%)

ALXN

Alexion

$126.07

-0.16 (-0.13%)

BA

Boeing

$202.23

2.79 (1.40%)

ORCL

Oracle

$50.95

0.65 (1.29%)

EQT

EQT Corporation

$56.19

4.16 (8.00%)

RICE

Rice Energy

$25.65

1.62 (6.74%)

SYK

Stryker

$141.12

-0.1 (-0.07%)

NVDQ

Novadaq

$11.78

-0.02 (-0.17%)

PRXL

Parexel

$86.80

-0.31 (-0.36%)

LH

LabCorp

$151.62

1.28 (0.85%)

ICLR

ICON plc

$96.37

-0.26 (-0.27%)

NKE

Nike

$52.85

0.45 (0.86%)

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

INTC

Intel

$34.19

-0.17 (-0.49%)

AMD

AMD

$14.15

-0.23 (-1.60%)

LZB

La-Z-Boy

$32.30

0.7 (2.22%)

RHT

Red Hat

$99.42

0.54 (0.55%)

AAL

American Airlines

$48.63

-0.34 (-0.69%)

HCA

HCA Holdings

$86.24

0.1 (0.12%)

LPNT

LifePoint

$65.50

-1.6 (-2.38%)

THC

Tenet

$18.52

-0.38 (-2.01%)

SCS

Steelcase

$13.65

-0.45 (-3.19%)

ACN

Accenture

$122.74

0.66 (0.54%)

BBBY

Bed Bath & Beyond

$29.65

-4.09 (-12.12%)

BBRY

BlackBerry

$9.71

-1.35 (-12.21%)

BAC

Bank of America

$22.82

-0.11 (-0.48%)

C

Citi

$63.41

-0.21 (-0.33%)

GS

Goldman Sachs

$217.19

-2.58 (-1.17%)

JPM

JPMorgan

$86.86

-0.16 (-0.18%)

MS

Morgan Stanley

$43.69

-0.92 (-2.06%)

WFC

Wells Fargo

$52.45

-0.04 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 23

    Jun

  • 26

    Jun

  • 26

    Jun

  • 26

    Jun

  • 26

    Jun

  • 28

    Jun

  • 28

    Jun

  • 28

    Jun

  • 29

    Jun

  • 29

    Jun

  • 29

    Jun

  • 06

    Jul

  • 07

    Jul

  • 13

    Jul

  • 14

    Jul

  • 14

    Jul

  • 18

    Jul

  • 19

    Jul

  • 25

    Jul

  • 25

    Jul

  • 26

    Jul

  • 30

    Jul

  • 14

    Aug

  • 29

    Aug

  • 12

    Oct

  • 12

    Oct

  • 17

    Oct

  • 23

    Oct

  • 14

    Nov

  • 15

    Jan

  • 03

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

16:39
06/23/17
06/23
16:39
06/23/17
16:39
General news
Moody's raises Greece rating to Caa2 from Caa3, outlook to positive from stable »

Moody's has upgraded…

CFCO

CF Corporation

$11.42

-0.04 (-0.35%)

16:38
06/23/17
06/23
16:38
06/23/17
16:38
Hot Stocks
Breaking Hot Stocks news story on CF Corporation »

Mason Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKS

AK Steel

$6.65

0.35 (5.56%)

, X

U.S. Steel

$22.25

1.18 (5.60%)

16:34
06/23/17
06/23
16:34
06/23/17
16:34
General news
On The Fly: Top stock stories for Friday »

Stocks opened in quiet…

AKS

AK Steel

$6.65

0.35 (5.56%)

X

U.S. Steel

$22.25

1.18 (5.60%)

PTLA

Portola Pharmaceuticals

$56.13

17.88 (46.75%)

BAC

Bank of America

$22.82

-0.11 (-0.48%)

C

Citi

$63.41

-0.21 (-0.33%)

GS

Goldman Sachs

$217.19

-2.58 (-1.17%)

JPM

JPMorgan

$86.86

-0.16 (-0.18%)

MS

Morgan Stanley

$43.69

-0.92 (-2.06%)

WFC

Wells Fargo

$52.45

-0.04 (-0.08%)

SNCR

Synchronoss

$16.24

4.06 (33.33%)

BBBY

Bed Bath & Beyond

$29.65

-4.09 (-12.12%)

BBRY

BlackBerry

$9.71

-1.35 (-12.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 23

    Jun

  • 23

    Jun

  • 24

    Jun

  • 26

    Jun

  • 29

    Jun

  • 14

    Jul

  • 14

    Jul

  • 18

    Jul

  • 25

    Jul

  • 25

    Jul

  • 12

    Oct

  • 12

    Oct

  • 17

    Oct

  • 15

    Jan

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.